| Financial Year |
March 31 2023 |
| Monetary Funds |
1,700,474,142.10 |
| Held-for-trading Financial Assets |
567,241.19 |
| Notes Receivable |
5,268,961.71 |
| Accounts Receivable |
821,276,151.17 |
| Advances to Suppliers |
62,693,796.04 |
| Other Receivables |
126,966,283.90 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,209,464,383.58 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
293,227,091.70 |
| Other Current Assets |
305,238,913.08 |
| Total Current Assets |
4,602,458,278.06 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
70,739,217.61 |
| Long-term Equity Investment |
255,079,979.24 |
| Investment Properties |
-- |
| Fixed Assetes |
1,857,947,169.99 |
| Under-construction Projects |
219,175,615.14 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
321,592,408.30 |
| R&D expenses |
-- |
| Goodwill |
195,120,893.19 |
| Long-Term Deferred and Prepaid Expenses |
392,920,440.49 |
| Deferred Income Tax Assets |
163,586,295.48 |
| Other Non-Current Assets |
104,225,910.21 |
| Sub-Total of Non-Current Assets |
3,970,415,559.90 |
| Total Assets |
8,572,873,837.96 |
| Short-Term Loans |
1,677,155,942.45 |
| Trading Financial liabilities |
2,846,329.96 |
| Notes Payable |
766,823,897.00 |
| Accounts Payable |
906,394,335.79 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
59,556,142.34 |
| Taxes Payable |
23,032,439.29 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
110,663,764.25 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
151,886,531.22 |
| Other Current Liabilities |
42,870,951.12 |
| Sub-Total of Current Liabilities |
3,968,816,671.47 |
| Long-term Loans |
480,238,249.54 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
29,687,663.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
819,293,856.26 |
| Total Liabilities |
4,788,110,527.73 |
| Paid-In Capital(Or Share Stock) |
387,417,787.00 |
| Capital Surplus |
1,324,286,489.49 |
| Surplus Reserve |
218,197,766.55 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,629,839,068.69 |
| Minority Stockholder's Interest |
224,301,335.71 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,560,461,974.52 |
| Owner's Equity（Stockholder's Equity） |
3,784,763,310.23 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
8,572,873,837.96 |
